Your session is about to expire
← Back to Search
Fluciclovine PET/CT for Muscle-Invasive Bladder Cancer
Study Summary
This trial is testing a new imaging agent to see if it can better detect bladder cancer that has spread to muscle tissue.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had cancer that needed treatment in the last 3 years.I am scheduled for a major bladder surgery after a specific PET/CT scan.I may or may not have had treatment to shrink my tumor before surgery.I can care for myself but may not be able to do active work.You have a strong fear of being in small, enclosed spaces.You have had allergic reactions to similar drugs as 18F-fluciclovine.I am 18 years old or older.I agree to use birth control before and 24 hours after my PET/CT scan.My cancer is at a stage where it has grown but not spread to lymph nodes.I do not have any serious illnesses or social situations that would stop me from following the study's requirements.My scans show no signs of cancer spread beyond the original site.My bladder cancer diagnosis was confirmed through lab tests.
- Group 1: 18F-fluciclovine
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are new participants being sought for this clinical experiment?
"Indeed, the data posted on clinicaltrials.gov indicates that this medical experiment is currently recruiting participants. It was first made accessible to the public on February 26th 2020 and received its latest update on April 4th 2022; 16 volunteers are needed from a single trial site."
How many participants are currently being recruited for this clinical experiment?
"Affirmative. Data from clinicaltrials.gov reveals that this medical trial, with its original post date of February 26th 2020, is currently recruiting patients for participation. 16 individuals are needed at one particular site."
Is this an unprecedented investigation?
"Currently, there are seven ongoing trials for 18F-fluciclovine conducted across 21 cities and one country. These studies began in 2019 when Telix International Pty Ltd sponsored a Phase 2 drug approval process involving 140 individuals. Since then, an additional 21 experiments have been carried out around the world."
Are there other investigations that have included 18F-fluciclovine in their research?
"Presently, 7 trials are being conducted with 18F-fluciclovine, one of which is in its final phase. Although the majority of studies related to this medication are taking place in Boston, Massachusetts; an additional 28 sites have also been enlisted for research purposes."
Share this study with friends
Copy Link
Messenger